US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Profusa Inc

1.53

-0.2407-13.60%

Volume:567.78K

Turnover:911.85K

Market Cap:1.88M

PE:-0.01

High:1.77

Open:1.75

Low:1.51

Close:1.77

52wk High:957.00

52wk Low:1.51

Shares:1.23M

Float Shares:1.11M

Volume Ratio:3.11

T/O Rate:51.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-278.6625

EPS(LYR):-123.5134

ROE:--

ROA:-465.14%

PB:-0.06

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

THOMSON REUTERS

Profusa Raises 2026 Revenue Guidance to $1.5M-$3M

Profusa Shares Decline After Equity Offer News

Profusa Inc: Files for Offering of up to 5.1 Mln Units & up to 5.1 Mln Pre-Funded Units - SEC Filing

THOMSON REUTERS

BRIEF-Profusa And Mayo Clinic Collaborate To Advance High-Impact Clinical Applications Of Oxygen Monitoring Technologies

Profusa Partners with Mayo Clinic to Advance Oxygen Monitoring Technologies

Profusa and Mayo Clinic Collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, Dynatrace

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:36 AM

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Profusa Enacts 1-for-75 Reverse Stock Split

Profusa Inc. Held Special Shareholder Meeting

Profusa Reports Positive US Clinical Trial Results for Lumee Sensor in PAD Patients

NASD Most Active Issues

Profusa Stock Spikes As Lumee System Targets Research Market

Benzinga_recent_news

Profusa Inc. Partners with Leading Greek Vascular Surgeon Dr. Theodosios Bisdas

Profusa Inc - Announces Distributor Partnership in France With Medsell

THOMSON REUTERS

Profusa Secures French Distribution Deal for Lumee Oxygen Monitoring with MedSell

Profusa Inc. Announces Private Placement of Up to $5 Million in Unregistered Shares

Profusa Inc - Restructures Senior Secured Convertible Note

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PFSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFSA\",,,,,undefined,":{"symbol":"PFSA","market":"US","secType":"STK","nameCN":"Profusa Inc","latestPrice":1.5293,"timestamp":1771525156296,"preClose":1.77,"halted":0,"volume":567775,"delay":0,"changeRate":-0.1359887005649717,"floatShares":1110600,"shares":1232000,"eps":-278.6625,"marketStatus":"Trading","change":-0.2407,"latestTime":"02-19 13:19:27 EST","open":1.75,"high":1.77,"low":1.51,"amount":911846.536445,"amplitude":0.146893,"askPrice":1.54,"askSize":1200,"bidPrice":1.51,"bidSize":17,"shortable":0,"etf":0,"ttmEps":-278.6625,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.77,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":1.77,"latestTime":"09:29 EST","volume":184558,"amount":342827.3923778,"timestamp":1771511341058,"change":-0.03,"changeRate":-0.016949,"amplitude":0.327684},"postHourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.77,"latestTime":"19:54 EST","volume":6491,"amount":10311.0195,"timestamp":1771462463276,"change":-0.16,"changeRate":-0.090395,"amplitude":0.20904},"volumeRatio":3.11008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFSA\",,,,,undefined,":{"symbol":"PFSA","floatShares":1110600,"roa":"-465.14%","roe":"--","lyrEps":-123.51345,"volumeRatio":3.11008,"shares":1232000,"dividePrice":0,"high":1.77,"amplitude":0.146893,"preClose":1.77,"low":1.51,"week52Low":1.51,"pbRate":"-0.06","week52High":957,"institutionHeld":0,"latestPrice":1.5293,"committee":-0.972062,"eps":-278.6625,"divideRate":0,"volume":567775,"delay":0,"ttmEps":-278.6625,"open":1.75,"prevYearClose":7.86,"prevWeekClose":2.01,"prevMonthClose":6.9525,"prevQuarterClose":7.86,"fiveDayClose":2.94,"twentyDayClose":8.595,"sixtyDayClose":10.1925},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-09","symbol":"PFSA","defaultRemindTime":1770647400000,"type":"split","dateTimestamp":1770613200000,"forFactor":75,"toFactor":1,"ratio":75},{"market":"US","date":"2025-11-19","symbol":"PFSA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763528400000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2025-08-14","symbol":"PFSA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-1.53},{"market":"US","date":"2025-07-14","symbol":"PFSA","reason":null,"defaultRemindTime":1752499800000,"announcedDate":"2025-07-11","type":"delisting","dateTimestamp":1752465600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFSA","date":"2026-02-18","current":-0.006352,"percent":1,"low":-6.696361,"twenty":-1.479091,"median":-0.981695,"eighty":-0.257416,"high":-0.073408,"avg":-1.018747,"sd":0.926357,"marketCap":2166111},"quantilePoints":[{"date":"2025-07-18","current":-3.831423,"twenty":-4.218017,"median":-4.073044,"eighty":-3.928071,"marketCap":36632233},{"date":"2025-07-25","current":-2.461085,"twenty":-3.824519,"median":-3.13935,"eighty":-2.657558,"marketCap":23530434},{"date":"2025-08-01","current":-2.416213,"twenty":-3.824519,"median":-2.892379,"eighty":-2.465917,"marketCap":23101408},{"date":"2025-08-08","current":-1.622314,"twenty":-3.665394,"median":-2.485247,"eighty":-2.03093,"marketCap":15510945},{"date":"2025-08-15","current":-1.874291,"twenty":-3.116154,"median":-2.382041,"eighty":-1.7463,"marketCap":17920092},{"date":"2025-08-22","current":-1.5672,"twenty":-2.970975,"median":-2.025131,"eighty":-1.723933,"marketCap":15378937},{"date":"2025-08-29","current":-1.37063,"twenty":-2.735429,"median":-1.883856,"eighty":-1.643688,"marketCap":13449997},{"date":"2025-09-05","current":-1.104323,"twenty":-2.631601,"median":-1.785563,"eighty":-1.5672,"marketCap":10836723},{"date":"2025-09-12","current":-1.54104,"twenty":-2.485247,"median":-1.725866,"eighty":-1.369962,"marketCap":15122230},{"date":"2025-09-19","current":-1.136066,"twenty":-2.461085,"median":-1.689106,"eighty":-1.253014,"marketCap":11148218},{"date":"2025-09-26","current":-1.008092,"twenty":-2.416213,"median":-1.636938,"eighty":-1.112008,"marketCap":9892404},{"date":"2025-10-03","current":-1.089955,"twenty":-2.347868,"median":-1.587854,"eighty":-1.089955,"marketCap":10695731},{"date":"2025-10-10","current":-1.130386,"twenty":-2.054126,"median":-1.437792,"eighty":-1.090289,"marketCap":11092477},{"date":"2025-10-17","current":-1.275947,"twenty":-2.025131,"median":-1.368291,"eighty":-1.098977,"marketCap":12584666},{"date":"2025-10-24","current":-1.130953,"twenty":-1.93297,"median":-1.33353,"eighty":-1.104323,"marketCap":11154590},{"date":"2025-10-31","current":-1.068813,"twenty":-1.89342,"median":-1.297252,"eighty":-1.104323,"marketCap":10541701},{"date":"2025-11-07","current":-0.776339,"twenty":-1.874291,"median":-1.273461,"eighty":-1.077592,"marketCap":7657034},{"date":"2025-11-14","current":-0.807824,"twenty":-1.828037,"median":-1.261487,"eighty":-1.030479,"marketCap":7967564},{"date":"2025-11-21","current":-0.562991,"twenty":-1.74309,"median":-1.23162,"eighty":-0.992053,"marketCap":5552779},{"date":"2025-11-28","current":-0.37684,"twenty":-1.742283,"median":-1.201379,"eighty":-0.946945,"marketCap":11119786},{"date":"2025-12-05","current":-0.403995,"twenty":-1.729109,"median":-1.192595,"eighty":-0.807161,"marketCap":11921093},{"date":"2025-12-12","current":-0.391753,"twenty":-1.723933,"median":-1.159952,"eighty":-0.778328,"marketCap":11559848},{"date":"2025-12-19","current":-0.250633,"twenty":-1.697769,"median":-1.13351,"eighty":-0.74063,"marketCap":7395675},{"date":"2025-12-26","current":-0.177179,"twenty":-1.688657,"median":-1.125039,"eighty":-0.51444,"marketCap":5228204},{"date":"2026-01-02","current":-0.233271,"twenty":-1.680392,"median":-1.109335,"eighty":-0.406755,"marketCap":6883364},{"date":"2026-01-09","current":-0.218135,"twenty":-1.657187,"median":-1.098977,"eighty":-0.389527,"marketCap":6436733},{"date":"2026-01-16","current":-0.219248,"twenty":-1.631088,"median":-1.083773,"eighty":-0.34541,"marketCap":6469574},{"date":"2026-01-23","current":-0.337949,"twenty":-1.619553,"median":-1.061173,"eighty":-0.336075,"marketCap":9972209},{"date":"2026-01-30","current":-0.271765,"twenty":-1.600246,"median":-1.030479,"eighty":-0.288458,"marketCap":8019246},{"date":"2026-02-06","current":-0.160482,"twenty":-1.561968,"median":-1.015944,"eighty":-0.271812,"marketCap":4735503},{"date":"2026-02-13","current":-0.117921,"twenty":-1.52039,"median":-0.99093,"eighty":-0.262824,"marketCap":3479604},{"date":"2026-02-18","current":-0.073408,"twenty":-1.479091,"median":-0.981695,"eighty":-0.257416,"marketCap":2166111}],"updateTime":1771497931240},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612002034","title":"Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2612002034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612002034?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:30","pubTimestamp":1771507850,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nFWN3ZF0KU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2612756400","title":"Profusa Raises 2026 Revenue Guidance to $1.5M-$3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2612756400","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612756400?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:30","pubTimestamp":1771507822,"startTime":"0","endTime":"0","summary":"Profusa Inc. raised its 2026 revenue guidance to $1.5 million–$3.0 million, up from its prior outlook of $0.5 million–$2.0 million. The company attributed the higher expectations to purchase orders for its Lumee tissue oxygen monitoring system in Europe and progress in its Healthcare Research business, signaling stronger anticipated performance in 2026 than previously projected.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire  on February 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL222jmY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4082","PFSA","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","SG9999014013.SGD","BK4588","LU2210150020.SGD","BK4585","SG9999014005.SGD","SG9999014039.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2611162770","title":"Profusa Shares Decline After Equity Offer News","url":"https://stock-news.laohu8.com/highlight/detail?id=2611162770","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611162770?lang=en_us&edition=fundamental","pubTime":"2026-02-14 02:30","pubTimestamp":1771007400,"startTime":"0","endTime":"0","summary":"Shares of biosensor company Profusa declined after it announced an equity offering.The stock opened at $2.76 Friday, remained below Thursday's close of $3.02 throughout the day, with a sharp decline after it said it would offer up to 5.1 million units. It recently traded down 28% to $2.17.Profusa said the units will each consist of a share or pre-funded warrant, plus two warrants.On Thursday, the company announced a collaboration with the Mayo Clinic, aiming to accelerate regulatory approval and commercialization of the Lumee oxygen monitoring product.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PFSA","BK4588","BK4082","BK4215","EQR"],"gpt_icon":0},{"id":"2611162388","title":"Profusa Inc: Files for Offering of up to 5.1 Mln Units & up to 5.1 Mln Pre-Funded Units - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611162388","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611162388?lang=en_us&edition=fundamental","pubTime":"2026-02-14 01:52","pubTimestamp":1771005156,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PFSA"],"gpt_icon":0},{"id":"2611111150","title":"BRIEF-Profusa And Mayo Clinic Collaborate To Advance High-Impact Clinical Applications Of Oxygen Monitoring Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2611111150","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611111150?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:49","pubTimestamp":1770990592,"startTime":"0","endTime":"0","summary":"BRIEF-Profusa And Mayo Clinic Collaborate To Advance High-Impact Clinical Applications Of Oxygen Monitoring TechnologiesFeb 13 (Reuters) - Profusa Inc PFSA.O:PROFUSA AND MAYO CLINIC COLLABORATE TO ADV","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"gpt_icon":0},{"id":"2611646908","title":"Profusa Partners with Mayo Clinic to Advance Oxygen Monitoring Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2611646908","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611646908?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:30","pubTimestamp":1770931811,"startTime":"0","endTime":"0","summary":"Profusa Inc., a commercial stage digital health company, has entered into a know-how agreement with Mayo Clinic to investigate high impact clinical applications of Profusa's oxygen monitoring technologies. The collaboration will focus on new product development and commercialization, targeting indications such as cardiovascular, renal, multi-organ, and orthopedic conditions where intra-organ postoperative perfusion monitoring could improve clinical outcomes. The partnership also supports Profusa's potential commercialization of its Lumee oxygen sensing and tissue monitoring technology for critical limb ischemia in the U.S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL7vhDmt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","SG9999014039.USD","BK4585","BK4082","IE00B64PRP62.GBP","LU2095319765.USD","PFSA","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","BK4588","LU2210149790.SGD"],"gpt_icon":0},{"id":"2611908681","title":"Profusa and Mayo Clinic Collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611908681?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:30","pubTimestamp":1770931800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA2PBSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2610654990","title":"BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, Dynatrace","url":"https://stock-news.laohu8.com/highlight/detail?id=2610654990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610654990?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:44","pubTimestamp":1770651885,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Edgewell, Waters Corp, DynatraceEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nL6N3Z50XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSFU","MSFO","LU1629891620.HKD","RIG","DT","BDX","APO","MSFW","MSFD","ITW","MSFL","HL","CLF","CCHH","CDE","EMR","BRLS","TDG","ORCX","DHX","APP","WDAY","MNTS","UOKA","WMT","VAL","ORCS","EXE","MSFX","ORCL","DXST","SBH","PFSA","KD","OFRM","CIFR","MSFY","LU0345768740.USD","EPC","NXST","MSFT","UBER","WAT","ORCU","WULF","HIMS","ODFL","TGNA","MBIN","KR"],"gpt_icon":0},{"id":"2610659511","title":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:36 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659511","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610659511?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:36","pubTimestamp":1770647762,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:36 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nAQN2LLFIB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2609734485","title":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2609734485","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609734485?lang=en_us&edition=fundamental","pubTime":"2026-02-08 16:28","pubTimestamp":1770539317,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260208:nAQN2LLDUY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"gpt_icon":0},{"id":"2609308831","title":"Profusa Enacts 1-for-75 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308831","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308831?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:00","pubTimestamp":1770296411,"startTime":"0","endTime":"0","summary":"Profusa Inc. has announced a 1-for-75 reverse stock split of its common stock, effective February 9, 2026. Following the split, the number of outstanding shares will decrease from approximately 92.4 million to about 1.2 million, while the number of authorized shares remains unchanged. The company will continue trading under the ticker symbol \"PFSA\" with a new CUSIP number.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL71JCmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4112","LU2095319765.USD","SG9999014005.SGD","BK4082","IE00B64PRP62.GBP","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","PFSA","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4588","BK4585"],"gpt_icon":0},{"id":"2608531818","title":"Profusa Inc. Held Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2608531818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608531818?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:31","pubTimestamp":1770067874,"startTime":"0","endTime":"0","summary":"Profusa Inc. held a Special Meeting of Stockholders on January 27, 2026. Stockholders approved an amendment to the Certificate of Incorporation to allow the Board of Directors to effect one or more reverse stock splits of the company's common stock at a ratio between 1-for-30 and 1-for-200, to be determined at the Board's discretion prior to January 27, 2028. The appointment of CBIZ CPAs P.C. as the company's independent registered public accounting firm for the year ending December 31, 2025, was ratified. Authorization was also given for potential adjournment of the Special Meeting to a later date if necessary.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief v","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL3Rm0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2607087671","title":"Profusa Reports Positive US Clinical Trial Results for Lumee Sensor in PAD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087671?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:00","pubTimestamp":1769691634,"startTime":"0","endTime":"0","summary":"Profusa Inc. has announced positive results from a US-based clinical study evaluating the Lumee sensor in patients with peripheral artery disease . The results, which were presented at the Leipzig Interventional Course  2026, showed that the sensors remained functional for up to one year and no sensor placement related adverse events were reported. The company expects to begin commercial activities in the European Union with Lumee oxygen revenue projected to commence in the second quarter of 2026, and estimates potential revenue of $0.5 to $2 million in 2026 and $9 to $13 million in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire  on Jan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL4NvGcS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","LU0314104364.USD","PFSA","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","BK4082","NDAQ","BK4585","SG9999014021.USD"],"gpt_icon":0},{"id":"2605142979","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2605142979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605142979?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:30","pubTimestamp":1768948200,"startTime":"0","endTime":"0","summary":"Super Micro Computer        SMCI    78,722,526     32.64     3.22     10.94. ProShares UltraPro QQQ      TQQQ    75,495,869     54.14    -0.24     -0.44. Strive Cl A                 ASST    61,986,970    0.9481    -0.02     -2.31. Direxion Dly TSLA Br 1X     TSLS    61,877,283      5.22     0.02      0.38. Invesco QQQ Trust I          QQQ    60,634,088    621.26    -0.52     -0.08. Direxion TSLA Bull 2X       TSLL    54,277,422     17.91    -0.07     -0.39","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU1861215975.USD","LU2750360997.AUD","LU1551013342.USD","LU0203345920.USD","TSLR","LU2471134796.USD","LU0719512351.SGD","LU2360107168.USD","BK4547","LU1720051017.SGD","LU0053666078.USD","IE00BK4W5M84.HKD","BK4532","LU1267930730.SGD","LU2125910500.SGD","LU2290526834.HKD","SG9999002406.SGD","LU0642271901.SGD","LU1629891620.HKD","SG9999015986.USD","BK4588","TQQQ","IE00BK4W5L77.USD","LU2063271972.USD","LU2458330169.SGD","LU0792757196.USD","LU2471134952.CNY","LU0532188223.SGD","IE00BJLML261.HKD","LU2471134879.HKD","LU2931357623.SGD","BK4543","CRSH","TSL","LU0345770308.USD","BK4122","TSLP","LU0943347566.SGD","BK4598","LU0466842654.USD","LU1548497426.USD","LU2756315664.SGD","SG9999015978.USD","TSLT","SG9999002414.USD","LU2756315318.SGD","LU2236285917.USD","TSLG","LU2326559502.SGD","TSLI","TSDD","LU0157215616.USD","LU0979878070.USD","IE00B1XK9C88.USD",".IXIC","TSLQ","LU0672654240.SGD","TSLY","SG9999001135.SGD","LU1674673691.USD","LU1778281490.HKD","LU2108987350.USD","LU0127658192.USD","SG9999015945.SGD","LU1066051225.USD","IE00BZ9MQY76.HKD","LU0321505868.SGD","LU2023250330.USD","LU2543165471.USD","SG9999013486.USD","LU0345769128.USD","BK4535","LU0198837287.USD","LU1366333091.USD","LU1720051108.HKD","TSLS","WMT","IE0034235303.USD","LU0820562030.AUD","SG9999015952.SGD","LU2148611432.USD","LU0053671581.USD","BK4512","BK4554","LU1914381329.SGD","IE00B19Z3581.USD","NVDA","IE00B1BXHZ80.USD","BK4604","BK4612","BK4550","LU1839390173.USD","LU1145028129.USD","IE00BSNM7G36.USD","LU0321505439.SGD","LU1861558580.USD","BK4585","LU0441851309.USD","LU2362541513.USD","04335","LU2602419157.SGD","LU0823414478.USD","LU0234570918.USD","BK4613","LU0708995401.HKD","IE00B894F039.SGD","BK4602","LU1366192091.USD","BK4555","BK4023","LU0823411888.USD","LU2456880835.USD","LU2471134523.USD","LU0274383776.USD","LU2462157665.USD","BK4605","BK4022","PFSA","LU1852331112.SGD","IE0002270589.USD","BK4575","LU1429558221.USD","BK4170","TSLL","BK4527","LU0210637038.USD","SG9999013460.SGD","TSLW","LU2211815571.USD","LU0056508442.USD","LU0820561909.HKD","SG9999002604.SGD","SG9999002679.SGD","LU0109392836.USD","LU1803068979.SGD","IE00B19Z9505.USD","LU2420271590.USD","BK4515","BK4551","BK4533","LU0348723411.USD","LU1551013425.SGD","LU2213496289.HKD","LU0345770993.USD","SG9999013478.USD","LU0689472784.USD","LU1861220033.SGD","BK4561","BK4511","BK4548","BK4593","LU2357305700.SGD","TSYY","LU0889565833.HKD","LU2896262040.SGD","LU2286300806.USD","LU1066053197.SGD","LU1242518931.SGD","IE00B19Z9P08.USD","BK4592","LU0210536198.USD","LU2362541273.HKD","GB00BDT5M118.USD","LU1839511570.USD","LU0097036916.USD","BK4574","BK4579","BK4581","IE00B19Z8X17.USD","LU2048586759.USD","LU1066051498.USD","SGXZ58947870.SGD","BK4141","LU0234572021.USD","LU2750360641.GBP","LU0889566641.SGD","LU0316494557.USD","LU2360106780.USD","TESL","BK4534","LU2249611893.SGD","LU1316542783.SGD","BK4099","BK4516","LU2045819591.USD","SG9999002620.SGD","IBRX","LU1242518857.USD","SG9999006266.SGD","LU1323610961.USD","LU1861559042.SGD","LU1232071149.USD","LU0320765059.SGD","LU1435385759.SGD","LU2417539215.USD","LU0109391861.USD","LU2087621335.USD","TSLZ","BK4529","LU0077335932.USD","LU2089985449.USD","IE00B19Z3B42.SGD","LU0345769631.USD","MULL","IE00B19Z9Z06.USD","LU0082616367.USD","LU1066051811.HKD","LU1267930813.SGD","LU0081259029.USD","LU2403377893.USD","BK4230","MUD","LU0820561818.USD","LU0964807845.USD","LU2458330243.SGD","LU0203347892.USD","BK4553","IE00B19Z8W00.USD","IE00B7SZLL34.SGD","IE00BWXC8680.SGD","BK4566","LU1674673428.USD","LU2250418816.HKD","AZN","LU0323591593.USD"],"gpt_icon":1},{"id":"2604491330","title":"Profusa Stock Spikes As Lumee System Targets Research Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2604491330","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604491330?lang=en_us&edition=fundamental","pubTime":"2026-01-17 01:51","pubTimestamp":1768585860,"startTime":"0","endTime":"0","summary":"Profusa shares surged on heavy volume after launching its Lumee tissue oxygen monitoring system for research use, targeting contract research organizations and near-term service revenue.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/16/Medical-Professionals-In-Research-And-De.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/16/Medical-Professionals-In-Research-And-De.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49973068/profusa-stock-spikes-as-lumee-system-targets-research-market","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","SMA","BK4082","PFSA"],"gpt_icon":0},{"id":"2601369705","title":"Profusa Inc. Partners with Leading Greek Vascular Surgeon Dr. Theodosios Bisdas","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369705","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369705?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:30","pubTimestamp":1767875420,"startTime":"0","endTime":"0","summary":"Profusa Inc. has announced the addition of Dr. Theodosios Bisdas, a renowned vascular surgeon and Head of the Clinic of Vascular Surgery at the Athens Medical Center in Greece, to its customer base. The collaboration will see Dr. Bisdas integrating Profusa’s Lumee Oxygen tissue monitoring system into his practice. Profusa expressed enthusiasm for working with Dr. Bisdas and exploring further clinical partnerships as the company continues to evaluate additional vascular applications for its platform technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL1bkttB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","PFSA","BK4588","LU2210149790.SGD","BK4082","SG9999014005.SGD","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2595779417","title":"Profusa Inc - Announces Distributor Partnership in France With Medsell","url":"https://stock-news.laohu8.com/highlight/detail?id=2595779417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595779417?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:30","pubTimestamp":1767184239,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nFWN3Y00M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2595441779","title":"Profusa Secures French Distribution Deal for Lumee Oxygen Monitoring with MedSell","url":"https://stock-news.laohu8.com/highlight/detail?id=2595441779","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595441779?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:30","pubTimestamp":1767184217,"startTime":"0","endTime":"0","summary":"Profusa Inc. announced a new distributor partnership with MedSell to commercialize its Lumee Oxygen tissue monitoring technology in France. MedSell will distribute the product in both hospital settings and outpatient care, particularly for wound care and healing clinics treating patients with complex and chronic wounds. This agreement expands Profusa’s European commercial network, which already includes distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia. Additionally, Profusa’s collaboration with Professor Yann Gouffic of Groupe Hospitalier Paris Saint Joseph continues, with the adoption of Lumee Oxygen monitoring technology in clinical practice and studies. Profusa aims to begin commercialization in Europe in the second quarter of 2026, targeting potential revenues of $0.5 to $2 million in 2026 and $9 to $13 million in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL8CyHL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","PFSA","BK4588","LU2210149790.SGD","BK4082","SG9999014005.SGD","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2595792584","title":"Profusa Inc. Announces Private Placement of Up to $5 Million in Unregistered Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595792584","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595792584?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:31","pubTimestamp":1767097903,"startTime":"0","endTime":"0","summary":"Profusa Inc. has announced an amendment to its Securities Purchase Agreement, allowing for the private placement of up to 13,650,000 shares of common stock at prices between $0.111 and $0.14 per share during a specified modification period ahead of an anticipated reverse stock split. Additionally, under the revised agreement, purchasers are obligated to buy additional notes with an aggregate principal amount of up to $5,555,556 for a purchase price of up to $5,000,000, contingent on certain conditions being met, including the reduction of outstanding balances from earlier tranches and the effectiveness of a registration statement covering the conversion shares. The amendments also adjust mandatory prepayment terms related to proceeds from equity offerings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL5TJ7YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"gpt_icon":0},{"id":"2595925587","title":"Profusa Inc - Restructures Senior Secured Convertible Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2595925587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595925587?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PFSA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}